OakChart

Tilray Brands Inc

TLRYHealthcare·Drug Manufacturers - Specialty & Generic·Canada·Small·NASD·Nov 11 • 9:14 AM ET

2.68+0.03 (1.13%)
2026-11-11 15:18 CET
Market cap
391.64 USD m
Revenue, TTM
963.10 USD m
Net income, TTM
-164.22 USD m
Free cash flow, TTM
-119.23 USD m
EPS diluted, TTM
-1.40
P/E
-
Compare

Price

TLRY against its 20, 50 and 200-day averages
2050200miss
4.006.008.0010.006.4M12.7MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26TLRYclose 2.6820-day 2.8250-day 3.48200-day 5.222.68

82.9% under 15.70 on 18 Dec 2025. Last 15 sessions, 20.7% high to low

Profile

TLRY
52-week range, 2% of the way up
2.4815.70

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Employees3595
IPOJul 19, 2018
Beta2.04
ATR, 14d0.17
Rel volume0.13
Short float13.43%
Insider own1.59%
Inst own9.81%

Snapshot

6 groups

Valuation

Index-
Market Cap396.07M
Enterprise Value529.93M
Income-164.22M
Sales963.10M
Book/sh11.29
Cash/sh1.50
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees3595
IPOJul 19, 2018

Ratios

P/E-
Forward P/E-
PEG-
P/S0.41
P/B0.24
P/C1.79
P/FCF-
EV/EBITDA52.11
EV/Sales0.55
Quick Ratio1.11
Current Ratio1.88
Debt/Eq0.23
LT Debt/Eq0.17
Option/ShortYes / Yes

Earnings

EPS (ttm)-1.40
EPS next Y-0.21
EPS next Q-0.16
EPS this Y48.39%
EPS next Y63.43%
EPS next 5Y67.72%
EPS past 3/5Y64.12% 39.71%
Sales past 3/5Y13.44% 12.28%
EPS Y/Y TTM93.85%
Sales Y/Y TTM15.93%
EPS Q/Q-10683.33%
Sales Q/Q22.74%
EarningsOct 08 BMO
EPS/Sales Surpr.-76.41% -3.42%

Ownership

Insider Own1.59%
Insider Trans0.64%
Inst Own9.81%
Inst Trans2.72%
ROA-7.45%
ROE-10.38%
ROIC-8.64%
Gross Margin26.82%
Oper. Margin-6.28%
Profit Margin-17.05%
SMA20-4.95%
SMA50-23.09%
SMA200-48.68%
Trades-

Technical

Shs Outstand147.79M
Shs Float145.44M
Short Float13.43%
Short Ratio4.69
Short Interest19.54M
52W High15.70 -82.93%
52W Low2.48 7.85%
Volatility7.60% 5.63%
ATR (14)0.17
RSI (14)37.18
Beta2.04
Rel Volume0.13
Avg Volume4.17M
Volume26,618

Performance

Perf Week-9.46%
Perf Month-18.04%
Perf Quarter-42.98%
Perf Half Y-50.92%
Perf YTD-70.32%
Perf Year-79.22%
Perf 3Y-83.95%
Perf 5Y-97.74%
Perf 10Y-
Recom2.40
Target Price5.72
Prev Close2.65
Price2.68
Change %1.13%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Apr 02, 2026UpgradeRRoth CapitalNeutral → Buy$10+273.1%
Jan 27, 2026InitiatedCCanaccord GenuityHold
Apr 05, 2024ReiteratedAAlliance Global PartnersNeutral$2.25 → $2.75+2.6%
Nov 02, 2022InitiatedBBernsteinMkt Perform$3.90+45.5%
Jul 29, 2022DowngradeTThe Benchmark CompanyHold → Sell$3+11.9%
Mar 04, 2022UpgradeCCanaccord GenuityHold → Buy$9+235.8%
Nov 18, 2021InitiatedBBarclaysUnderweight$10+273.1%
Nov 01, 2021DowngradeCCantor FitzgeraldOverweight → Neutral$18 → $11.80+340.3%
Jun 11, 2021DowngradeCCIBCSector Outperform → Neutral$25+832.8%
Jun 03, 2021UpgradeCCantor FitzgeraldNeutral → Overweight$30.25 → $22+720.9%

Peers

Mkt cap
TickerCompanyMkt cap
CGCCanopy Growth Corp260.83M
ACBAurora Cannabis Inc330.78M
CRONCronos Group Inc1.25B
OGIOrganigram Global Inc121.25M
GLASGlass House Brands Inc152.54M
SNDLSNDL Inc343.09M
TRLVTrulieve Cannabis Corp2.15B
HITIHigh Tide Inc230.87M
VFFVillage Farms International Inc329.04M
SAMBoston Beer Co Inc2.23B

Insider trading

latest 14 of 24
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
SIMON IRWIN DPresident and CEOAug 26 '26Option Exercise0.001,212,16801,734,920Aug 27 08:00 PM
Merton Carl AChief Financial OfficerAug 26 '26Option Exercise0.00168,4520276,646Aug 27 08:00 PM
Gendel MitchellGlobal General CounselAug 26 '26Option Exercise0.00160,3040258,392Aug 27 07:59 PM
FALTISCHEK DENISE MChief Strategy OfficerAug 26 '26Option Exercise0.00178,2210288,657Aug 27 07:59 PM
Gendel MitchellGlobal General CounselAug 06 '26Buy4.432,50011,075124,883Aug 07 09:29 AM
Merton Carl AChief Financial OfficerAug 04 '26Buy4.6210,00046,200139,753Aug 04 01:36 PM
FALTISCHEK DENISE MChief Strategy OfficerAug 03 '26Buy4.782,50011,950141,285Aug 04 10:58 AM
SIMON IRWIN DPresident and CEOJul 30 '26Option Exercise0.00117,6470801,666Jul 31 05:53 PM
SIMON IRWIN DPresident and CEOJul 29 '26Option Exercise0.00428,4480911,097Jul 31 05:53 PM
Merton Carl AChief Financial OfficerJul 30 '26Option Exercise0.0016,6560138,914Jul 31 05:53 PM
Merton Carl AChief Financial OfficerJul 29 '26Option Exercise0.0060,4170152,467Jul 31 05:53 PM
Gendel MitchellGlobal General CounselJul 30 '26Option Exercise0.0024,3790135,304Jul 31 05:53 PM
Gendel MitchellGlobal General CounselJul 29 '26Option Exercise0.0087,4400157,269Jul 31 05:53 PM
FALTISCHEK DENISE MChief Strategy OfficerJul 30 '26Option Exercise0.0026,1200152,629Jul 31 05:52 PM

Held by

AUM
TickerCompanyAUM
MJAmplify Alternative Harvest ETFAUM: 98.28M
VHTVanguard Health Care ETFAUM: 21.51B
SMLFiShares U.S. Small-Cap Equity Factor ETFAUM: 4.26B
FHLCFidelity MSCI Health Care Index ETFAUM: 4.12B
PDNInvesco RAFI Developed Markets ex-U.S. Small-Mid ETFAUM: 342.42M
ISCViShares Morningstar Small-Cap Value ETFAUM: 699.52M
SPDWState Street SPDR Portfolio Developed World ex-US ETFAUM: 41.64B
WSMLiShares MSCI World Small-Cap ETFAUM: 672.84M
MSMLiShares MSCI USA Small-Cap ETFAUM: 278.65M

News

latest 14 of 103
  • Whiskey You Won't Find on Shelves: Breckenridge Distillery Launches the 2 Mile High Whiskey Club (GlobeNewswire)
  • Aurora Cannabis Record International Medical Revenue Quarterly Update Report (Exec Edge) -7.02%
  • Tilray Brands targets $20M in cost savings after craft brewery closures (Food Dive)
  • Tilray Brands Consolidates Canadian Cannabis Operations and Raises FY2027 EBITDA Guidance (InvestorsHub)
  • Tilray Brands Announces Strategy to Strengthen Canadian Cannabis Operations and Drive Profitable Growth (GlobeNewswire)
  • Loading…
  • Tilrays beverage business poised for volume growth as Carlsberg deal date nears, says Jefferies (Proactive)
  • Breckenridge Distillery and University of Denver Athletics Release Limited-Edition Whiskey Celebrating Record 11th NCAA Men's Hockey Championship (GlobeNewswire)
  • Tilray Brands Announces Next Phase of Beverage Transformation (GlobeNewswire)
  • Blue Point Brewing Co.'s Legendary Cask Ales Festival Returns to Patchogue with 100+ Limited-Release Brews (GlobeNewswire)
  • West Ham United F.C. and BrewDog Unveil Boleyn Brew: A Fan-Created Matchday Beer Made by Hammers, for Hammers (GlobeNewswire)
  • SweetWater Brewing Gives Fans the Chance to Win Tickets to Their Dream Show at AEG Venues Across Georgia (GlobeNewswire)
  • Tilray Medical Strengthens Global Medical Cannabis Supply Chain with Approval to Bring Critical EU-GMP Quality Testing In-House, Accelerating Product Release Across Regulated Global Markets (GlobeNewswire)
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive) -5.08%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q12026-10-08-0.320-0.181-0.320257.15266.267
2025Q42026-07-28-0.430-0.012-0.429281.71246.35
2025Q32026-04-01-0.224-0.136-0.236206.73201.355
2025Q22026-01-08-0.410-0.214-0.407217.51210.943
2025Q12025-10-090.000-0.266-0.003209.5204.554
2024Q42025-07-28-13.000-0.235-13.015224.54232.235
2024Q32025-04-08-8.700-0.375-8.691185.78206.847
2024Q22025-01-10-1.000-0.338-0.987210.95216.348
2024Q12024-10-10-0.400-0.350-0.447200218.78
2023Q42024-07-29-0.400-0.229-0.400229.88226.27
2023Q32024-04-09-1.200-0.500-1.229188.34197.189
2023Q22024-01-09-0.700-0.513-0.671193.77193.688
2023Q12023-10-04-1.000-0.513-1.035176.95174.38
2022Q42023-07-26-1.500-0.413-2.112184.19153.968
2022Q32023-04-10-19.000-0.557-19.024145.59150.027
2022Q22023-01-09-1.100-0.567-1.136144.14154.7912

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-32.000-14.150-31.971166.98174.98
2020FY-21.500-24.288-13.631210.48208.03
2021FY-9.000-0.764-9.908695.21629.33
2022FY-23.500-22.222-23.506627.12598.26
2023FY-3.300-3.096-3.299788.94784.96
2024FY-24.600-11.824-24.561821.31829.83
2025FY-1.090-0.642-1.090915.45877.98
2026FY--0.563--1,104
2027FY--0.206--1,158
2028FY--0.037--1,183
2029FY-0.125--1,198
2030FY-0.185--1,206

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q2S2026-10-30909264.71245.6272
2026Q2S2026-10-28918265.01245.6272
2026Q2S2026-10-12918265.01245.6272
2026Q2S2026-10-09918264.98245.6272
2026Q2S2026-10-08918266.96245.6279.7
2026Q2S2026-10-05935270.08249.3279.7
2026Q2S2026-10-02934270.36249.3282.2
2026Q2S2026-10-01943270.9249.3282.2
2026Q2S2026-09-30942272.32249.4287.8
2026Q2S2026-09-18933270.84249.4287.8
2026Q2S2026-09-11942272.72249.4287.8
2026Q2S2026-09-10942272.68249.4287.8
2026Q2S2026-08-04942272.72249.4287.8
2026Q2S2026-07-30942272.71249.4287.8

Estimate history

EPS, annual-0.838-8.158-31.971-13.631-9.908-23.506-3.299-24.561-1.086-1.3957
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.447-0.987-8.691-13.015-0.003-0.407-0.236-0.429-0.324
PeriodQ1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Sales, annual20.53843.13166.979513.085628.372627.124788.942821.309915.454963.1
Period201720182019202020212022202320242025TTM
Sales, quarterly200.044210.95185.78224.535209.501217.507206.732281.714257.147
PeriodQ1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Shares, annual9.3149.31710.27844.64453.26765.66683.193105.867131.094143.811
Period201720182019202020212022202320242025MRQ
Shares, quarterly87.54492.55897.375105.867111.508116.201116.226131.094143.811
PeriodQ1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2020FY2019FY
Total Revenue963.10915.45821.31788.94627.12628.37513.09210.48166.98
Cost of Goods Sold Incl. D&A704.78674.60669.36650.34573.65626.75425.12199.01202.08
Gross Profit258.32240.86151.95138.6053.471.6387.9611.48-35.10
Selling, General and Administrative Excl. Other318.83296.12259.77251.36231.67230.86156.52138.79181.45
Research and Development0.410.360.280.640.681.520.834.416.56
Other Operating Expense0.000.000.000.006.500.000.000.000.00
Operating Income-60.51-55.26-107.81-112.76-184.69-229.24-68.56-127.31-216.56
Interest Expense23.4529.9141.3349.2646.6139.6830.9039.2234.69
Unusual Expense29.1312.102,171.8087.361,216.25154.27232.83109.4380.64
Net Income Before Taxes-125.59-88.06-2,302.37-249.02-1,450.18-440.67-344.53-270.69-325.12
Income Taxes21.1117.10-121.02-26.62-7.18-6.54-8.97-5.60-8.45
Consolidated Net Income-146.70-105.16-2,181.36-222.40-1,443.00-434.13-336.01-271.07-321.17
Net Income From Continuing Operations-164.22-121.40-2,186.74-244.98-1,452.66-476.80-367.42-271.07-321.17
Net Income-164.22-121.40-2,186.74-244.98-1,452.66-476.80-367.42-271.07-321.17
EPS (Recurring)-1.08-1.01-7.49-2.48-9.73-7.66-7.58-1.54-26.35
EPS (Basic, Before Extraordinaries)-1.40-1.09-24.56-3.30-23.51-9.91-13.63-2.15-31.97
EPS (Diluted)-1.40-1.09-24.56-3.30-23.51-9.91-13.63-2.15-31.97
EBITDA10.1712.3425.6814.15-54.55-74.64-0.73-108.66-200.71
Non-Operating Income (Expense)-12.519.2118.570.36-2.62-17.49-12.235.276.77
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense37.5036.2919.1923.3531.2826.4612.7521.8423.40
Price To Sales Ratio0.630.670.461.691.653.448.764.9510.31
Gross Margin26.8226.3118.5017.578.530.2617.145.45-21.02
Operating Margin-6.28-6.04-13.13-14.29-29.45-36.48-13.36-60.49-129.69
Net Margin-17.05-13.26-266.25-31.05-231.64-75.88-71.61-128.79-192.34
Shares Outstanding143.81131.09105.8783.1965.6753.2744.64158.4610.28
Market Capitalization391.64391.64414.531,497.471,096.612,391.7129,859.131,308.851,760.64

Income statement, quarterly

Currency USD, millions
Metric2026Q12025Q42025Q32025Q22025Q12024Q42024Q32024Q2
Total Revenue257.15281.71206.73217.51209.50224.53185.78210.95
Cost of Goods Sold Incl. D&A186.14197.38156.88164.37155.96177.61156.95172.66
Gross Profit71.0184.3349.8553.1453.5446.9328.8338.29
Selling, General and Administrative Excl. Other87.1388.8469.7273.1564.4159.5960.2372.44
Research and Development0.090.180.060.080.040.030.090.06
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-16.12-4.51-19.87-20.01-10.87-12.66-31.40-34.15
Interest Expense6.486.634.975.376.703.978.387.77
Unusual Expense7.9911.906.852.39-9.051,430.40727.397.71
Net Income Before Taxes-38.31-24.07-23.26-39.96-0.77-1,393.04-792.33-83.24
Income Taxes1.7313.861.973.55-2.29-125.141.202.04
Consolidated Net Income-40.03-37.93-25.23-43.511.51-1,267.90-793.53-85.28
Net Income From Continuing Operations-43.14-49.57-26.57-44.93-0.32-1,272.80-789.44-85.34
Net Income-43.14-49.57-26.57-44.93-0.32-1,272.80-789.44-85.34
EPS (Recurring)-0.28-0.36-0.19-0.39-0.06-2.78-3.09-0.92
EPS (Basic, Before Extraordinaries)-0.32-0.43-0.24-0.41-0.00-13.01-8.69-0.99
EPS (Diluted)-0.32-0.43-0.24-0.41-0.00-13.01-8.69-0.99
EBITDA2.5214.83-3.13-4.054.6921.422.14-0.10
Non-Operating Income (Expense)-7.72-1.038.42-12.197.7553.99-25.16-33.61
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense5.2011.7610.849.703.994.823.195.72
Price To Sales Ratio0.630.701.031.071.760.510.811.40
Gross Margin27.6129.9324.1124.4325.5620.9015.5218.15
Operating Margin-6.27-1.60-9.61-9.20-5.19-5.64-16.90-16.19
Net Margin-16.78-17.60-12.85-20.66-0.15-566.86-424.93-40.46
Shares Outstanding143.81131.09116.23116.20111.51105.8797.3892.56
Market Capitalization391.64659.02916.91906.561,460.97414.53715.711,173.10

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2020FY2019FY2018FY
Cash & Short Term Investments234.63256.36260.52448.53415.91488.47189.7096.79517.59
Short Term Receivables189.17121.49101.6986.2395.2889.7941.1643.0417.49
Inventories301.19270.88252.09200.55245.53256.4393.6487.8616.21
Other Current Assets67.1439.8963.4137.7246.7948.9222.5231.343.01
Total Current Assets792.13688.63677.71773.03803.50883.61347.02259.03554.30
Net Property, Plant & Equipment722.54590.71574.35435.61600.50668.97217.54201.7380.21
Total Investments and Advances6.5510.137.86115.77126.2025.7923.6735.6316.91
Long-Term Note Receivable-0.0032.00------
Intangible Assets795.80773.772,924.352,982.633,919.184,438.71353.36392.084.49
Deferred Tax Assets28.0442.34113.6390.43-----
Other Assets10.9811.085.390.220.318.294.367.860.75
Total Assets2,356.052,116.664,335.304,397.695,449.696,025.36945.95896.33656.67
Short Term Debt Incl. Current Port. of LT Debt40.2928.8938.96224.2692.6549.604.413.970.47
Accounts Payable114.54107.35105.3970.8268.6057.7117.7839.0610.65
Income Tax Payable12.670.064.0914.936.1514.76---
Other Current Liabilities190.88144.01150.73122.96112.94279.17159.0949.4014.82
Total Current Liabilities358.38280.30299.17432.98280.34401.24181.2892.4325.94
Long Term Debt358.11299.85348.36365.87531.16889.06336.88465.18428.65
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities40.2946.09244.50257.79196.64265.8549.2753.364.42
Other Liabilities4.400.850.0911.100.193.914.610.090.00
Total Liabilities761.18627.09892.121,067.741,008.331,560.05572.05611.06459.01
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity1,614.331,511.473,442.913,315.694,398.814,459.07373.90285.27197.65
Total Shareholders Equity1,614.331,511.473,442.913,315.694,398.814,459.07373.90285.27197.65
Accumulated Minority Interest-19.46-21.900.2714.2542.566.240.000.000.00
Total Equity1,594.871,489.583,443.183,329.944,441.374,465.31373.90285.27197.65
Total Liabilities & Stockholders Equity2,356.052,116.664,335.304,397.695,449.696,025.36945.95896.33656.67
Book Value Per Share12.3114.2841.3850.4982.5899.882.3627.7621.21
Tangible Book Value Per Share6.246.976.235.079.000.460.13-10.3920.73
Full-Time Employees3,5952,8422,6501,6001,7002,1001,0301,646688
Price to Book Ratio0.230.150.430.330.5455.233.506.1733.25
Return on Assets-5.43-67.79-5.61-29.50-8.31-10.62-29.43-41.36-19.06
Return on Equity-7.77-88.27-7.25-37.66-10.77-15.49-82.25-133.01-70.25
Return on Invested Capital-6.15-120.73-6.46-39.46-9.67-6.87-38.14-42.80-10.81
Quick Ratio1.371.491.421.321.991.561.401.8520.75
Current Ratio2.212.462.271.792.872.201.912.8021.37

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2020FY2019FY
Net Income-147.13-105.16-2,181.36-222.40-1,443.00-434.13-336.01-271.07-321.17
Depreciation70.9567.60133.49126.91130.15154.5967.8318.6515.85
Other Funds (Non Cash)56.0238.672,136.85112.331,338.31220.91299.27188.38176.67
Funds from Operations1.0218.22-32.04-22.03-6.49-85.496.22-69.42-137.50
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-85.64-87.36-62.56-8.8714.40-91.77-50.94-59.94-120.57
Cash from Operating Activities-84.62-69.14-94.60-30.917.91-177.26-44.72-129.35-258.07
Capital Expenditures-34.61-32.99-32.92-29.25-20.80-34.06-38.87-44.64-78.62
Net Assets From Acquisitions-54.64-53.70-18.11-60.63-26.720.000.000.00-163.89
Sale of Fixed Assets and Businesses3.333.516.828.514.3012.5373.222.666.58
Purchase or Sale of Investments-3.8327.38-2.52209.72-241.900.000.000.30-14.57
Purchase of Investments-3.61-4.60-2.520.00-241.900.000.00-3.76-1,398.20
Sale Or Maturity of Investments-0.2231.970.00209.720.000.000.004.071,383.63
Other Uses0.000.000.000.000.000.00-2.420.00-2.69
Other Sources0.000.000.000.000.000.0014.180.000.00
Cash from Investing Activities-89.75-55.80-46.72128.35-285.11-21.5346.11-41.68-253.18
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock160.84160.34161.198.62128.40262.51102.69220.20111.52
Repurchase of Common Pref Stock0.000.000.000.00-1.190.000.00-1.26-5.01
Sale of Common Pref Stock160.84160.34161.198.62129.59262.51102.69221.47116.53
Proceedsfrom Stock Options158.46157.97161.198.62129.59262.51102.55209.97111.07
Issuance or Reduction of Debt, Net-28.14-23.76-23.24-80.91-57.13-118.8746.5744.793.69
Change in Long Term Debt-28.65-25.35-12.39-75.56-62.39-128.2838.2444.793.69
Issuance of Long Term Debt0.000.003.4554.17146.340.00102.8046.404.19
Reduction of Long Term Debt-28.65-25.35-15.84-129.73-208.73-128.28-64.56-1.61-0.50
Net Financing Active Other Cash Flow-0.16-0.16-1.540.000.00-10.77-23.90-0.150.00
Other Financing Activities Uses-0.16-0.16-1.540.000.00-10.77-23.90-1.500.00
Cash from Financing Activities125.64130.99133.51-75.1970.16128.20124.31264.85114.70
Exchange Rate Effect2.271.631.14-0.55-2.23-1.962.12-0.916.08
Net Change in Cash-46.457.68-6.6721.71-209.28-72.56127.8292.91-390.46
Free Cash Flow-119.23-102.13-127.52-60.15-12.89-211.33-83.59-174.00-331.81
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-17.10-121.02-38.87-31.95-27.54-24.87-5.38-8.85

Balance sheet, quarterly

Currency USD, millions
Metric2026Q12025Q42025Q32025Q22025Q12024Q4
Cash & Short Term Investments221.39234.63264.82291.55264.83256.36
Short Term Receivables190.62189.17118.37109.07107.08121.49
Inventories328.97301.19292.30283.20282.79270.88
Other Current Assets66.6167.1443.2745.5046.4539.89
Total Current Assets807.59792.13718.76729.32701.14688.63
Net Property, Plant & Equipment707.95722.54560.95569.90581.16590.71
Total Investments and Advances6.376.557.6314.2211.1610.13
Intangible Assets795.54795.80776.31774.09777.52773.77
Deferred Tax Assets-28.04---42.34
Other Assets10.5110.9811.0711.0711.6611.08
Total Assets2,327.952,356.052,074.722,098.602,082.652,116.66
Short Term Debt Incl. Current Port. of LT Debt95.2740.2933.5532.8931.9628.89
Accounts Payable133.60114.54115.33114.50110.80107.35
Income Tax Payable15.6012.670.001.911.040.06
Other Current Liabilities186.21190.88108.66110.02123.83144.01
Total Current Liabilities430.69358.38257.54259.31267.63280.30
Long Term Debt276.66358.11283.53286.74291.79299.85
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities9.7540.297.885.621.9446.09
Other Liabilities4.194.400.160.420.630.85
Total Liabilities721.28761.18549.12552.09561.99627.09
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity1,623.361,614.331,557.371,579.831,540.741,511.47
Total Shareholders Equity1,623.361,614.331,557.371,579.831,540.741,511.47
Accumulated Minority Interest-16.68-19.46-31.76-33.32-20.09-21.90
Total Equity1,606.671,594.871,525.611,546.511,520.661,489.58
Total Liabilities & Stockholders Equity2,327.952,356.052,074.722,098.602,082.652,116.66
Book Value Per Share11.2912.3113.4013.6013.8214.28
Tangible Book Value Per Share5.766.246.726.936.846.97
Full-Time Employees-3,595---2,842
Price to Book Ratio0.230.410.580.590.970.15
Return on Assets-7.45-5.43-49.09-67.01-67.71-67.79
Return on Equity-10.38-7.77-62.73-83.42-85.59-88.27
Return on Invested Capital-2.27-2.51-1.44-2.41-0.02-70.27
Quick Ratio1.111.371.661.721.561.49
Current Ratio1.882.212.792.812.622.46

Cash flow, quarterly

Currency USD, millions
Metric2026Q12025Q42025Q32025Q22025Q12024Q4
Net Income-40.03-38.07-25.85-43.171.51-1,275.32
Depreciation18.6419.4117.2015.7015.5635.73
Other Funds (Non Cash)10.8111.8410.1923.18-6.381,359.96
Funds from Operations-8.867.093.54-0.758.41-2.29
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-7.68-44.56-25.69-7.71-9.75-12.00
Cash from Operating Activities-16.54-37.47-22.15-8.46-1.34-14.28
Capital Expenditures-11.01-10.19-3.87-9.54-9.52-6.79
Net Assets From Acquisitions-0.72-53.920.000.000.00-0.25
Sale of Fixed Assets and Businesses0.101.721.380.130.295.96
Purchase or Sale of Investments2.3811.0031.11-48.3233.7013.34
Purchase of Investments0.000.0010.01-13.63-1.0013.34
Sale Or Maturity of Investments2.3811.0021.10-34.7034.700.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-9.25-51.3928.63-57.7324.4712.25
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock22.3485.250.9352.3222.4923.98
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock22.3485.250.9352.3222.4923.98
Proceedsfrom Stock Options22.3485.250.9049.9722.4923.98
Issuance or Reduction of Debt, Net-5.93-14.36-4.05-3.79-1.65-3.32
Change in Long Term Debt-5.85-14.30-4.34-4.16-2.650.35
Issuance of Long Term Debt0.000.000.000.000.000.07
Reduction of Long Term Debt-5.85-14.30-4.34-4.16-2.650.29
Net Financing Active Other Cash Flow0.000.00-0.160.000.00-1.53
Other Financing Activities Uses0.000.00-0.160.000.00-1.53
Cash from Financing Activities13.9768.44-4.3147.5519.8518.77
Exchange Rate Effect0.830.170.970.310.194.26
Net Change in Cash-11.00-20.253.12-18.3343.1620.99
Free Cash Flow-27.55-47.66-26.02-18.00-10.86-21.08

Revenue breakdown

Total Medicinal Chemicals & Botanical Products revenue2024: 821.31M 2025: 915.45M
Canada2024: 212.86M 2025: 215.66M
EMEA2024: 323.35M 2025: 445.70M
Rest of World2024: 11.40M 2025: 11.71M
United States2024: 273.70M 2025: 242.39M
Beverage Alcohol Business2024: 240.60M 2025: 253.98M
Cannabis2024: 249.00M 2025: 268.34M
Distribution Business2024: 271.23M 2025: 327.24M
Wellness Business2024: 60.49M 2025: 65.89M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3013.43%19.5M145.4M4.06M
2026-10-1514.80%21.5M145.4M4.21M
2026-09-3012.94%18.8M145.2M4.06M
2026-09-1514.58%19.4M133.2M4.03M
2026-08-3113.56%18.1M133.2M4.04M
2026-08-1413.76%18.4M134.0M4.00M
2026-07-3115.60%20.8M133.7M3.98M
2026-07-1513.62%16.2M119.1M4.99M
2026-06-3014.94%17.8M119.1M4.87M
2026-06-1515.40%18.3M118.7M4.66M
2026-05-2913.04%15.5M118.7M4.50M
2026-05-1514.16%16.8M118.7M4.41M
2026-04-3016.36%19.4M118.7M4.23M
2026-04-1512.44%14.4M115.6M2.95M
2026-03-3112.32%14.3M115.6M3.64M
2026-03-1313.33%15.4M115.6M7.48M
2026-02-2714.42%16.7M115.6M9.50M
2026-02-1312.85%14.9M115.6M9.75M
2026-01-3013.71%15.9M115.6M9.90M
2026-01-1513.12%15.2M115.6M10.30M

Option chain

expiry 2026-11-13
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call0.500.000.002.16-19.000.00---
call1.000.000.001.68-77.000.00---
call1.500.000.001.20-33.000.00---
call2.000.000.000.77-8.000.00---
call2.500.000.000.20-2340.00---
call3.000.000.000.02-3,3090.00---
call3.500.000.000.01-1,5570.00---
call4.000.000.000.01-4270.00---
call4.500.000.000.01-79.000.00---
call5.000.000.000.05-13.000.00---
call5.500.000.000.02-51.000.00---
call6.000.000.000.01-2160.00---
call6.500.000.000.01-1510.00---
call7.000.000.000.01-4740.00---
call7.500.000.000.01-2080.00---
put0.500.000.000.02-1.000.00---
put1.000.000.000.00-0.000.00---
put1.500.000.000.00-0.000.00---
put2.000.000.000.01-17.000.00---
put2.500.000.000.02-3870.00---
put3.000.000.000.37-5660.00---
put3.500.000.000.80-28.000.00---
put4.000.000.001.37-23.000.00---
put4.500.000.001.74-13.000.00---
put5.000.000.002.28-19.000.00---
put5.500.000.002.89-8.000.00---
put6.000.000.003.38-10.000.00---
put6.500.000.003.82-9.000.00---
put7.000.000.004.45-5.000.00---
put7.500.000.004.95-5.000.00---

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-0810-QQuarterly report pursuant to Section 13 or 15(d)2026-08-31SEC
2026-10-088-KCurrent report2026-10-08SEC
2026-09-28ARSAnnual report to security holders. 2026-05-31SEC
2026-09-28DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-09-28DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-11-18SEC
2026-09-18PRE 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-11-18SEC
2026-09-148-KCurrent report2026-09-08SEC
2026-08-274Statement of changes in beneficial ownership of securities2026-08-26SEC
2026-08-274Statement of changes in beneficial ownership of securities2026-08-26SEC
2026-08-274Statement of changes in beneficial ownership of securities2026-08-26SEC
2026-08-274Statement of changes in beneficial ownership of securities2026-08-26SEC
2026-08-108-KCurrent report2026-08-04SEC
2026-08-074Statement of changes in beneficial ownership of securities2026-08-06SEC
2026-08-044Statement of changes in beneficial ownership of securities2026-08-04SEC
2026-08-044Statement of changes in beneficial ownership of securities2026-08-03SEC
2026-07-314Statement of changes in beneficial ownership of securities2026-07-29SEC
2026-07-314Statement of changes in beneficial ownership of securities2026-07-29SEC
2026-07-314Statement of changes in beneficial ownership of securities2026-07-29SEC
2026-07-314Statement of changes in beneficial ownership of securities2026-07-29SEC
2026-07-31S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-07-304Statement of changes in beneficial ownership of securities2026-07-29SEC
2026-07-304Statement of changes in beneficial ownership of securities2026-07-29SEC
2026-07-304Statement of changes in beneficial ownership of securities2026-07-29SEC
2026-07-304Statement of changes in beneficial ownership of securities2026-07-29SEC
2026-07-304Statement of changes in beneficial ownership of securities2026-07-29SEC
2026-07-304Statement of changes in beneficial ownership of securities2026-07-29SEC
2026-07-2810-KAnnual report pursuant to Section 13 or 15(d)2026-05-31SEC
2026-07-288-KCurrent report2026-07-28SEC
2026-06-308-KCurrent report2026-06-24SEC
2026-06-098-KCurrent report2026-06-03SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-0869.23K300
2026-070000
2026-060000
2026-050000
2026-0400232.88K1
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
Tidal Investments LLC2.08%
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.85%
UBS Group AG0.85%
MORGAN STANLEY0.83%
CITADEL ADVISORS LLC0.72%
Point72 Asset Management, L.P.0.54%
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.0.54%
AQR CAPITAL MANAGEMENT LLC0.43%
BlackRock, Inc.0.38%
LAZARD ASSET MANAGEMENT LLC0.33%

Funds

Fund% owned
Amplify Alternative Harvest ETF2.06%
VANGUARD HEALTH CARE INDEX FUND0.26%
iShares U.S. Small-Cap Equity Factor ETF0.06%
AdvisorShares Pure Cannabis ETF0.06%
Dimensional International Small Cap ETF0.06%
State Street(R) SPDR(R) S&P(R) International Small Cap ETF0.05%
Fidelity MSCI Health Care Index ETF0.04%
The Canadian Small Company Series0.03%
Fidelity Nasdaq Composite Index ETF0.03%
World ex U.S. Core Equity Portfolio0.03%

OakChart. TLRY. Cached 15 minutes.